Table 5.
Incidence of complications in both groups.
| Complication | Ropivacaine group | Control group | P value |
|---|---|---|---|
| PONV | 10/33 | 19/35 | 0.046 |
| Wound infection | 1/33 | 1/35 | >0.99 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.